Amylyx Announces $5 Million Series A Financing to Support Phase II Clinical Trial of AMX0035 for Treatment of Amyotrophic Lateral Sclerosis Pharmaceutical Investing
RespireRx Pharmaceuticals Inc. Files June 30, 2016 Quarterly Report on Form 10-Q Life Science Investing
DelMar Pharmaceuticals to Present at the 11th Biennial Ovarian Cancer Research Symposium Life Science Investing
OncBioMune Announce Latest Data From Phase 1 Trial of ProscaVax for Prostate Cancer Life Science Investing
Adamis Pharmaceuticals Strengthens Patent Portfolio for its Dry Powder Inhaler Life Science Investing
Dr. Mark L. Rabe Presents PharmaCyte Biotech’s Ongoing Research at Cannabis Cancer Forum Biotech Investing
